Meeting Banner
Abstract #3418

Pre-Therapy Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) Predicts Response of Metastatic Breast Cancer to Liposomal Irinotecan

Harshan Ravi1, Andres M. Arias Lorza1, James R. Costello2, Hyo Sook Han3, Daniel K. Jeong2, Stephan G. Klinz Klinz4, Jasgit C. Sachdev5, Ronald L. Korn6, and Natarajan Raghunand1,7
1Department of Cancer Physiology, Moffitt Cancer Center and Research Institute, Tampa,, FL, United States, 2Department of Radiology, Moffitt Cancer Center and Research Institute, Tampa,, FL, United States, 3Department of Breast Oncology, Moffitt Cancer Center and Research Institute, Tampa,, FL, United States, 4Ipsen Bioscience, Cambridge, MA, United States, 5HonorHealth Research Institute, Scottsdale, AZ, United States, 6Imaging Endpoints Core Lab, Scottsdale, AZ, United States, 7Department of Oncologic Sciences, University of South Florida, Tampa,, FL, United States

Synopsis

R*2 and the apparent concentration of FMX in the tumor (FMXC) are considered biomarkers of liposomal irinotecan (nal-IRI) drug uptake into that tumor lesion, which in turn would determine response of that tumor to nal-IRI. Historically, quantification of R*2 and FMXC had been implemented by using a calibration phantom and acquiring patient scans both pre-FMX and post-FMX. Here we have demonstrated a pre-treatment FMX-enhanced MRI companion biomarker of response to nal-IRI in mBC patients that can be computed from a single16-24 h post-FMX MRI scan without the need for calibration phantoms or pre-FMX scans.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords